BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19899766)

  • 1. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
    Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
    J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of 7,8-dihydropteroate synthase from Bacillus anthracis: mechanism and novel inhibitor design.
    Babaoglu K; Qi J; Lee RE; White SW
    Structure; 2004 Sep; 12(9):1705-17. PubMed ID: 15341734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of Mycobacterium tuberculosis 7,8-dihydropteroate synthase in complex with pterin monophosphate: new insight into the enzymatic mechanism and sulfa-drug action.
    Baca AM; Sirawaraporn R; Turley S; Sirawaraporn W; Hol WG
    J Mol Biol; 2000 Oct; 302(5):1193-212. PubMed ID: 11007651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
    Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of novel pyrimido[4,5-c]pyridazine derivatives as dihydropteroate synthase inhibitors with increased affinity.
    Zhao Y; Hammoudeh D; Yun MK; Qi J; White SW; Lee RE
    ChemMedChem; 2012 May; 7(5):861-70. PubMed ID: 22416048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
    Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
    Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of bi-substrate state mimics of dihydropteroate synthase as potential inhibitors and molecular probes.
    Qi J; Virga KG; Das S; Zhao Y; Yun MK; White SW; Lee RE
    Bioorg Med Chem; 2011 Feb; 19(3):1298-305. PubMed ID: 21216602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydropteroate synthase from Streptococcus pneumoniae: structure, ligand recognition and mechanism of sulfonamide resistance.
    Levy C; Minnis D; Derrick JP
    Biochem J; 2008 Jun; 412(2):379-88. PubMed ID: 18321242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
    Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
    Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of Burkholderia cenocepacia dihydropteroate synthase in the apo-form and complexed with the product 7,8-dihydropteroate.
    Morgan RE; Batot GO; Dement JM; Rao VA; Eadsforth TC; Hunter WN
    BMC Struct Biol; 2011 May; 11():21. PubMed ID: 21554707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of intrinsic sulfonamide resistance in Bacillus anthracis: a novel assay for dihydropteroate synthase.
    Valderas MW; Andi B; Barrow WW; Cook PF
    Biochim Biophys Acta; 2008 May; 1780(5):848-53. PubMed ID: 18342015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
    Rao GS; Kumar M
    Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
    Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
    Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
    Vinnicombe HG; Derrick JP
    Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
    Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
    J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic basis for sulfonamide resistance in Bacillus anthracis.
    Valderas MW; Bourne PC; Barrow WW
    Microb Drug Resist; 2007; 13(1):11-20. PubMed ID: 17536929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel and potent inhibitors for dihydropteroate synthase of
    Satuluri SH; Katari SK; Pasala C; Amineni U
    J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalysis and sulfa drug resistance in dihydropteroate synthase.
    Yun MK; Wu Y; Li Z; Zhao Y; Waddell MB; Ferreira AM; Lee RE; Bashford D; White SW
    Science; 2012 Mar; 335(6072):1110-4. PubMed ID: 22383850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
    Das BK; Pv P; Chakraborty D
    Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of the 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase•dihydropteroate synthase bifunctional enzyme from Francisella tularensis.
    Pemble CW; Mehta PK; Mehra S; Li Z; Nourse A; Lee RE; White SW
    PLoS One; 2010 Nov; 5(11):e14165. PubMed ID: 21152407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.